Company Overview and News

 
Shares fall as investors weight up Fletcher rights issue

2018-04-17 nzherald.co.nz
New Zealand shares fell as investors weighed up the impact of Fletcher Building's deeply discounted rights issue soaking up demand from the broader market. Auckland International Airport and exporters A2 Milk Co and Comvita dropped.
Upvote Downvote

1
Comment: Why it's time to bank on a greener future

2018-04-16 nzherald.co.nz
Imagine this as an elaborate web that wraps around the globe, each thread an exchange of capital from one entity to another, from the smallest microfinance loans to the largest transactions among countries and multinational corporations.
Upvote Downvote

 
MARKET CLOSE: NZ shares gain, risk-on for Synlait and A2 as Sky TV rises

2018-03-27 nbr.co.nz
New Zealand shares rose, led by Synlait Milk and a2 Milk Co, with Sky Network Television rebounding from yesterday's selling.
Upvote Downvote

 
NZ shares gain; Synlait, A2 and Sky TV rise

2018-03-27 nzherald.co.nz
New Zealand shares rose, led by Synlait Milk and a2 Milk Co, with Sky Network Television rebounding from yesterday's selling.
Upvote Downvote

 
NZ shares follow Asian markets lower

2018-03-01 nzherald.co.nz
New Zealand shares joined a regionwide sell-off with Asian equity markets following Wall Street lower as global investors second-guess the outlook for US interest rates, and as local analysts absorb a "pretty good" earnings season. Sky Network Television fell for a second day.
Upvote Downvote

 
MARKET CLOSE: NZ shares gain for fifth day, led by Synlait on North Island plans

2018-02-27 nbr.co.nz
New Zealand shares rose for a fifth day, following overseas markets higher, led by Synlait Milk after the milk processor bought a plot in Waikato for a new manufacturing facility.
Upvote Downvote

 
New Zealand shares follow overseas markets higher

2018-02-27 nzherald.co.nz
New Zealand shares rose for a fifth day, following overseas markets higher, led by Synlait Milk after the milk processor bought a plot in Waikato for a new manufacturing facility.
Upvote Downvote

 
Wet and dry - power firms' results a tale of two islands

2018-02-27 nzherald.co.nz
Reporting season was a tale of two islands for the electricity sector as dry South Island conditions sapped first-half earnings for Contact Energy and Meridian Energy, forcing them to lean on backstop Genesis Energy, while Mercury NZ's North Island hydro schemes were inundated with rain.
Upvote Downvote

 
Meridian Energy profits fall 12.8 percent from last year

2018-02-21 radionz.co.nz
Meridian Energy's first-half profit is down as its power generation dropped 16 percent on the year earlier.
Upvote Downvote

 
Fran O'Sullivan: Norris made right choice in resigning

2018-02-14 nzherald.co.nz
Sir Ralph Norris effectively fired himself as chairman at Fletcher Building, taking accountability for the billion-dollar fiasco with troubled construction projects.
Upvote Downvote

 
Genesis Energy lifts first-half earnings 28 per cent on demand for wholesale electricity

2018-02-13 nzherald.co.nz
Genesis Energy lifted first-half earnings 28 per cent as low hydro-lake levels in the South Island boosted the company's demand for wholesale electricity and announced plans to completely phase out coal use by 2030.
Upvote Downvote

 
Why Fletcher's Ralph Norris fell on his sword

2018-02-13 nzherald.co.nz
Corporate heavyweight Sir Ralph Norris said Fletcher Building investors expect the board to be accountable and so announced his resignation as chairman today.
Upvote Downvote

 
Contact Energy to sell its electricity to Tiwai Point

2018-02-13 radionz.co.nz
Contact Energy says it is selling its electricity at a cheap price to the Tiwai Point aluminium smelter partly to help it stay in business.
Upvote Downvote

 
Big name stocks fall, dragging down sharemarket

2018-02-12 nzherald.co.nz
New Zealand shares dropped, led by Kathmandu Holdings and Fisher & Paykel Healthcare, while NZX gained.
Upvote Downvote

 
Contact Energy profit slumps 11pct due to dry spell

2018-02-11 nzherald.co.nz
Contact Energy's first-half earnings fell 11 per cent as the electricity generator-retailer dealt with a dry spell, which sapped its hydro generation in what it described as a "highly competitive" market.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 615252905